Ledger.Open graph →
SEC Form D · filed April 30, 2021

Treeline Biosciences, Inc

Offering
$220.0M
Sold
$211.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
STAMFORD, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven H. Elms · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorDavid H. Bonita · Stamford, CTDirectorKristina H. Burow · Stamford, CTDirectorJoshua H. Bilenker · Stamford, CTExec · Director · PromoterJeffrey H. Engelman · Stamford, CTExec · Director · PromoterDavid H. Schenkein · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorSteven H. Elms · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorDavid H. Bonita · Stamford, CTDirectorKristina H. Burow · Stamford, CTDirectorJoshua H. Bilenker · New York, NYExec · Director · PromoterJeffrey H. Engelman · Stamford, CTExec · Director · PromoterDavid H. Schenkein · Stamford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗